HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OraLabs

This article was originally published in The Rose Sheet

Executive Summary

Third quarter revenues fell nearly 4% to $2.8 mil., a loss of $.08 per share, while net loss was $360,205, compared to net income of $33,431 in 2003. Parker, Colo. firm attributes lackluster results to expenses associated with the company's relocation, which contributed to reduced gross profit and a reported loss. OraLabs remains optimistic, noting, "the company is going into its busy season and we are hopeful that our expansion investments will pay off." OraLabs manufacturers lip care products such as ChapIce, Chap Grip and Soothe & Shine, as well as Ice Drops breath drops and sprays...

You may also be interested in...



Dr Reddy’s International Business Makes Up For Domestic Decline

Dr Reddy’s saw growth particularly in Europe, North America and international markets in the firm’s financial first quarter ended June 2020. However, the company’s domestic business saw a decline of a due to the impact of COVID-19.

EU Designates 6th German Notified Body Under MDR As German/Italian Divide Grows

The latest EU designation means Germany now has six notified bodies under the MDR and Italy only one.

EU Guidance Explains How And When MDSAP Audits Can Offer Auditing Shortcuts

This is the busiest time in the history of notified bodies as they try to process all manufacturers under the EU Medical Device Regulation (MDR). Making use of MDSAP audits is one way to cut down on work but is not always an option. The EU’s latest guidance explains the detail.

UsernamePublicRestriction

Register

LL1132992

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel